Lucas Augusto Moyses Franco
Overview
Explore the profile of Lucas Augusto Moyses Franco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santamarina A, Filho V, de Freitas J, Franco L, Martins R, Fonseca J, et al.
Mol Nutr Food Res
. 2025 Feb;
:e202400806.
PMID: 39981988
This study explores the effects of a nutraceutical blend with prebiotics, β-glucans, essential minerals, and silymarin on gut microbiota, inflammation, and sleep quality in obesity through microbiota reshaping and metabolic...
2.
Moreira C, Bierrenbach A, Taconeli C, Oliveira-da Silva L, Buss L, Keating S, et al.
Front Parasitol
. 2025 Jan;
2():1235925.
PMID: 39816837
Background: Evaluating the effectiveness of Chagas disease treatment poses challenges due to the lack of biomarkers for disease progression and therapeutic response. In this study, we aimed to assess the...
3.
Santamarina A, Filho V, de Freitas J, Franco L, Fonseca J, Martins R, et al.
Nutrients
. 2024 Sep;
16(18).
PMID: 39339649
Stress, unhealthy lifestyle, and sleep disturbance worsen cognitive function in mood disorders, prompting a rise in the development of integrative health approaches. The recent investigations in the gut-brain axis field...
4.
Santamarina A, de Freitas J, Franco L, Nehmi-Filho V, Fonseca J, Martins R, et al.
Sci Rep
. 2024 May;
14(1):11127.
PMID: 38750102
Nutraceutical interventions supporting microbiota and eliciting clinical improvements in metabolic diseases have grown significantly. Chronic stress, gut dysbiosis, and metainflammation have emerged as key factors intertwined with sleep disorders, consequently...
5.
Amato V, Franco L, de Souza R, da Silva C, Ramundo M, Cortes M, et al.
Am J Trop Med Hyg
. 2023 Dec;
110(2):228-233.
PMID: 38109765
In situ and systemic evaluations of the immune responses of HIV-infected patients to mucosal leishmaniasis have been poorly described. We describe a recently diagnosed HIV-infected patient with mucosal leishmaniasis who...
6.
Garcez F, de Alencar J, Fernandez S, Avelino-Silva V, Sabino E, Martins R, et al.
J Gerontol A Biol Sci Med Sci
. 2023 Mar;
78(8):1320-1327.
PMID: 36869725
Our aim was to investigate the association between gut microbiota and delirium occurrence in acutely ill older adults. We included 133 participants 65+ years consecutively admitted to the emergency department...
7.
Mendes E, Villagelin Neto D, Ferreira G, Valenca I, Lima M, de Freitas M, et al.
Am J Infect Control
. 2022 Nov;
51(3):248-254.
PMID: 36375707
Background: Reducing the transmission of SARS-CoV-2 from asymptomatic and pre-symptomatic patients is critical in controlling the circulation of the virus. Methods: This study evaluated the prevalence of Reverse transcription polymerase...
8.
Sabino E, Franco L, Venturini G, Velho Rodrigues M, Marques E, Oliveira-da Silva L, et al.
PLoS Negl Trop Dis
. 2022 Oct;
16(10):e0010725.
PMID: 36215317
Background: Chronic Chagas Cardiomyopathy (CCC) usually develops between 10 and 20 years after the first parasitic infection and is one of the leading causes of end-stage heart failure in Latin...
9.
Oliveira B, de Oliveira L, Mendes de Oliveira F, Pereira G, de Souza R, Manuli E, et al.
Rev Inst Med Trop Sao Paulo
. 2022 Oct;
64:e63.
PMID: 36197424
COVID-19 disease is spread worldwide and diagnostic techniques have been studied in order to contain the pandemic. Immunochromatographic (IC) assays are feasible and a low-cost alternative especially in low and...
10.
Amato V, de Souza R, Franco L, Martins R, da Silva C, Emori C, et al.
Am J Trop Med Hyg
. 2022 Sep;
107(4):785-788.
PMID: 36067991
The immunosuppressive effect of methotrexate has rarely been associated with reactivation of cutaneous leishmaniasis. Here we present a case of a cutaneous leishmaniasis patient with atypical clinical symptoms without splenomegaly...